tiprankstipranks
CanSino Biologics, Inc. Class H (HK:6185)
:6185
Hong Kong Market
6185
CanSino Biologics, Inc. Class H
RESEARCH TOOLSreports

CanSino Biologics, Inc. Class H (6185) Ratios

5 Followers

CanSino Biologics, Inc. Class H Ratios

HK:6185's free cash flow for Q4 2025 was ¥0.65. For the 2025 fiscal year, HK:6185's free cash flow was decreased by ¥ and operating cash flow was ¥-0.07. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
 0.00 0.00 2.42 2.00 2.63
Quick Ratio
 0.00 0.00 2.26 1.86 2.40
Cash Ratio
 0.00 0.00 0.88 0.79 1.15
Solvency Ratio
 -0.04 0.00 -0.05 -0.30 -0.17
Operating Cash Flow Ratio
 0.00 0.00 -0.10 -0.35 -0.64
Short-Term Operating Cash Flow Coverage
 0.00 0.00 -0.19 -0.66 -1.20
Net Current Asset Value
¥ 4.93B¥ 1.79B¥ 1.23B¥ 1.15B¥ 3.51B
Leverage Ratios
Debt-to-Assets Ratio
 0.00 0.00 0.25 0.29 0.24
Debt-to-Equity Ratio
 0.00 0.00 0.41 0.51 0.40
Debt-to-Capital Ratio
 0.00 0.00 0.29 0.34 0.29
Long-Term Debt-to-Capital Ratio
 0.00 0.00 0.18 0.17 0.12
Financial Leverage Ratio
 0.00 0.00 1.62 1.77 1.70
Debt Service Coverage Ratio
 9.12 0.00 -0.14 -1.12 -0.68
Interest Coverage Ratio
 1.02 0.00 -6.26 -31.73 -33.11
Debt to Market Cap
 0.00 0.00 0.27 0.49 0.17
Interest Debt Per Share
 0.08 0.00 8.37 11.20 11.10
Net Debt to EBITDA
 0.00 0.87 -3.39 -0.40 0.53
Profitability Margins
Gross Profit Margin
100.00%0.00%71.12%-253.78%-18.10%
EBIT Margin
2.04%2.24%-44.33%-554.70%-145.39%
EBITDA Margin
19.40%2.24%-15.93%-476.76%-127.91%
Operating Profit Margin
2.24%2.24%-44.33%-589.60%-132.75%
Pretax Profit Margin
2.04%2.04%-45.04%-573.29%-114.84%
Net Profit Margin
2.61%2.61%-44.77%-429.55%-88.21%
Continuous Operations Profit Margin
2.61%2.04%-45.33%-569.97%-93.57%
Net Income Per EBT
128.22%128.22%99.39%74.93%76.81%
EBT Per EBIT
90.90%90.90%101.59%97.23%86.50%
Return on Assets (ROA)
0.00%0.38%-4.76%-15.91%-7.93%
Return on Equity (ROE)
0.57%0.55%-7.72%-28.11%-13.48%
Return on Capital Employed (ROCE)
0.00%-1.85%-6.07%-30.25%-16.05%
Return on Invested Capital (ROIC)
0.00%-1.76%-5.29%-24.72%-10.99%
Return on Tangible Assets
0.00%0.39%-4.93%-16.27%-8.11%
Earnings Yield
0.14%0.34%-5.17%-29.34%-6.25%
Efficiency Ratios
Receivables Turnover
 0.00 0.00 1.07 0.50 1.21
Payables Turnover
 0.00 0.00 3.91 11.75 4.81
Inventory Turnover
 0.00 0.00 0.87 3.46 1.80
Fixed Asset Turnover
 0.00 0.00 0.32 0.11 0.33
Asset Turnover
 0.00 0.00 0.11 0.04 0.09
Working Capital Turnover Ratio
 0.75 0.00 0.33 0.09 0.18
Cash Conversion Cycle
 0.00 580.69 667.73 811.21 430.15
Days of Sales Outstanding
 0.00 280.49 342.13 736.82 302.85
Days of Inventory Outstanding
 0.00 352.80 418.89 105.46 203.17
Days of Payables Outstanding
 0.00 52.60 93.29 31.08 75.87
Operating Cycle
 0.00 633.29 761.02 842.28 506.02
Cash Flow Ratios
Operating Cash Flow Per Share
 0.17 0.00 -0.68 -3.71 -7.64
Free Cash Flow Per Share
 -0.45 0.00 -2.53 -6.19 -11.99
CapEx Per Share
 0.61 0.00 1.85 2.47 4.35
Free Cash Flow to Operating Cash Flow
 -2.66 0.00 3.71 1.67 1.57
Dividend Paid and CapEx Coverage Ratio
 0.23 0.00 -0.32 -1.49 -1.49
Capital Expenditure Coverage Ratio
 0.27 0.00 -0.37 -1.50 -1.76
Operating Cash Flow Coverage Ratio
 0.00 0.00 -0.08 -0.34 -0.70
Operating Cash Flow to Sales Ratio
 0.05 0.00 -0.20 -2.65 -1.83
Free Cash Flow Yield
-1.07%-1.92%-8.55%-30.21%-20.35%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 698.00 292.71 -19.34 -3.41 -16.01
Price-to-Sales (P/S) Ratio
 11.41 7.64 8.66 14.64 14.12
Price-to-Book (P/B) Ratio
 3.95 0.00 1.49 0.96 2.16
Price-to-Free Cash Flow (P/FCF) Ratio
 -93.86 0.00 -11.70 -3.31 -4.91
Price-to-Operating Cash Flow Ratio
 398.59 0.00 -43.41 -5.52 -7.71
Price-to-Earnings Growth (PEG) Ratio
 5.54 -2.73 0.26 -0.05 0.11
Price-to-Fair Value
 3.95 0.00 1.49 0.96 2.16
Enterprise Value Multiple
 58.82 0.00 -57.72 -3.47 -10.51
Enterprise Value
 12.18B 8.00B 7.78B 5.71B 13.87B
EV to EBITDA
 58.82 131.20 -57.72 -3.47 -10.51
EV to Sales
 11.41 7.75 9.20 16.53 13.45
EV to Free Cash Flow
 -93.86 -52.35 -12.42 -3.74 -4.68
EV to Operating Cash Flow
 249.63 246.27 -46.11 -6.23 -7.35
Tangible Book Value Per Share
 16.91 0.00 18.73 20.59 28.28
Shareholders’ Equity Per Share
 16.91 0.00 19.83 21.37 27.32
Tax and Other Ratios
Effective Tax Rate
 -0.28 0.00 >-0.01 <0.01 0.19
Revenue Per Share
 3.66 4.11 3.42 1.40 4.17
Net Income Per Share
 0.10 0.11 -1.53 -6.01 -3.68
Tax Burden
 1.28 1.28 0.99 0.75 0.77
Interest Burden
 1.00 -0.19 1.02 1.03 0.79
Research & Development to Revenue
 0.42 0.00 0.49 1.85 0.75
SG&A to Revenue
 0.73 0.00 0.67 0.85 0.27
Stock-Based Compensation to Revenue
 <0.01 0.00 0.00 0.03 <0.01
Income Quality
 1.75 1.20 0.44 0.62 1.59
Currency in CNY